This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 21/3/674    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by zur Nieden, N. I. Articles by Rancourt, D. E. Search for Related Content PubMed PubMed Citation Articles by zur Nieden, N. I. Articles by Rancourt, D. E.

Gene Profiling on Mixed Embryonic Stem Cell Populations Reveals a Biphasic Role for ß-Catenin in Osteogenic Differentiation

University of Calgary, Faculty of Medicine, Institute of Maternal and Child Health, Calgary, Alberta, Canada T2N 4N1

Address all correspondence and requests for reprints to: Nicole I. zur Nieden, Fraunhofer Institute for Cell Therapy and Immunology, Deutscher Platz 5e, 04103 Leipzig, Germany. E-mail: nicole.zurnieden{at}izi.fraunhofer.de.

The differentiation of embryonic stem cells (ESCs) into osteoblasts is enhanced to 60% when exposed to vitamin D₃ (VD₃) but leaves a remainder of one half of the cell population unidentified. To increase differentiation outcome, the known osteoinducers retinoic acid (RA) and bone morphogenetic protein-2 (BMP-2) were evaluated. Initial studies using RA and BMP-2 during early osteogenesis in addition to VD₃ increased osteogenic yield in the case of RA, but surprisingly decreased osteogenesis when BMP-2 was administered together with VD₃ or RA. This paper describes a comprehensive microarray study examining the gene expression profile of differentiating osteoblasts in these mixed ESC populations. In addition to five other families of signaling molecules (insulin growth factors, prostaglandin, follistatin, TGFß₂, and Wnt molecules), we identified an endogenous expression pattern for BMPs and RA that differed from our previous exogenous administration of these molecules. By mimicking the change in expression of the RA and BMP-2 families with exogenous supplementation at the correct time, it was then possible to increase the number of ESC-derived osteoblasts to 90%. This effect was mediated through alteration in ß-catenin (CatnB) expression levels and nuclear CatnB activity, both of which are modulated by VD₃, RA, and BMP-2. Our results suggest that blockage of CatnB activity by VD₃ and RA is opposed by induction of CatnB activity through BMP-2 when administered together. Hence, osteoinduction, in vitro, is an intricate process involving both temporal and quantitative changes in gene expression and CatnB activity.